| Meeting of Turkish and Russian Young Hematologists |
IV. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS PROGRAM
09-13 OCTOBER 2013
09 October 2013 Wednesday |
|||||
16:00-16:30 |
Opening Speech |
Dr. Suleyman Dincer |
|||
The Opening Session of the Congress |
|||||
16:30-17:00 |
Treatment of Acute Myeloid Leukemia: Are We Making Progress? |
Dr. Alan Burnett |
|||
17:00-17:30 |
New Strategies With Minimal Residual Disease and Targeted Therapy in Adult Acute Lymphoblastic Leukemia |
Dr. Dieter Hoelzer |
|||
17:30-18:00 |
Debate: HL Therapy in 2013: Possible Approaches |
Dr. Alessandro Levis |
|||
18:00-18:30 |
Iron Overload in MDS |
Dr. Eliezer Rachmilewitz |
|||
18:30-19:00 |
Cancer Stem Cells: An Update |
Dr. Albert Donnenberg |
|||
19:00 |
Opening Cocktail |
||||
10 October 2013 Thursday |
|||||
Complications and Hematologic Infections Sessions |
|||||
09:00-09:30 |
New Antibiotic Strategy in Neutropenia |
Dr. Omrum Uzun |
|||
09:30-10:00 |
The Patient at the Centre of IFI Management: Putting Theory Into Practice |
Dr. Samir Agrawal |
|||
10:00-10:30 |
Profilactic Anti Fungal Treatment in Hematologic Malignancies |
Dr. Esin Senol |
|||
10:30-10:45 |
Coffee Break |
||||
MPN |
|||||
10.45-11:15 |
Molecular Genetics of MPNs |
Dr. Daniela Cilloni |
|||
11:15-11:45 |
Therapeutic Advances in MPN |
Dr. Selim Yavuz |
|||
11:45-12:15 |
Transplantation in MPN |
Dr. Francesco Frassoni |
|||
12:15-12:45 |
Evidence based management of Essential Thrombocythemia |
Dr. Petro E. Petrides |
|||
12:45-13:30 |
Lunch Break |
||||
ALL |
|||||
13:30-14:00 |
Moleculer Genetics of ALL |
Dr. Sabina Chiaretti |
|||
14:00-14:30 |
Ph+ ALL New Era |
Dr. Mohamed Said Yousuf Ahmed |
|||
14:30-15:00 |
Transplantation in ALL Acute Lymphoblastic Leukemia in Adolescents Between Pediatric and Adult Camps |
Dr. Mohamed Said Yousuf Ahmed |
|||
15:00-15:15 |
Coffee Break |
||||
MDS |
|||||
15:15-15:45 |
Recent Clinical and Molecular Advances in the Management of MDS Patients |
Dr. Peter Greenberg |
|||
15:45-16:15 |
New Drugs in MDS Treatment |
Dr. Florian Nolte |
|||
16:15-16:45 |
In Elderly Patients With AML Which Patients Should be Considered Fit or Unfit for Standart Induction Therapy? |
Dr. Mehmet Ali Ozcan |
|||
16:45-17:15 |
Myelodysplastic Syndromes: Who and When Should Be Transplanted in the Disease Process? |
Dr. Francesco Frassoni |
|||
CML |
|||||
17:15-17:45 |
CML Successful Targeted Therapy |
Dr. Guray Saydam |
|||
17:45-18:15 |
Is Going For Cure in Chronic Myeloid Leukemia Possible and Justifiable? |
Dr. Giuseppe Saglio |
|||
11 October 2013 Friday |
|||||
CLL and Indolent Lymphomas |
|||||
09:00-09:30 |
Implications of New Prognostic Markers in Chronic Lymphocytic Leukemia |
Dr. Emili Montserrat |
|||
09:30-10:00 |
Emerging Role of Kinase-Targeted Strategies in Chronic Lymphocytic Leukemia |
Dr. Paolo Ghia |
|||
10:00-10:30 |
In The Hematological Malignancies, Minimal Residual Disease Criteria During the First Diagnose |
Dr. Nikolai Tupitsyn |
|||
10:30-11:00 |
Low Grade Lymphoma Treatment Strategy |
Dr. Berksoy Sahin |
|||
11:00:11:15 |
Coffee Break |
||||
High Grade Lymphomas |
|||||
11:45-12:15 |
Therapy of DLCLs |
Dr. Alessandro Levis |
|||
12:15-12:45 |
In DLBL’s Treatment When Autogous and When Allogenic Therapy Will Apply? |
Dr. Evren Ozdemir |
|||
12:45-13:30 |
Lunch Break |
||||
STC |
|||||
13:30-14:00 |
Advances in Mobilization Failure |
Dr. Nabih Azar |
|||
14:00-14:30 |
Autologous BMT |
Dr. Alev Erikci |
|||
14:30-15:00 |
Bone Marrow Transplantation: Haploidentical Transplantation |
Dr. Mustafa Cetin |
|||
15:00-15:15 |
Coffee Break |
||||
Multiple Myeloma |
|||||
15:15-15:45 |
How to Use New Biology to Guide Therapy in Multiple Myeloma |
Dr. Michel Delforge |
|||
15:45-16:15 |
The Treatment of Posttransplantation in Multiple Myeloma: Minimal Residual Disease Control |
Dr. Sergey Samanskiy |
|||
16:15-16:45 |
Doublets, Triplets, or Quadruplets of Novel Agents in Newly Diagnosed Myeloma? |
Dr. Rafat Abanour |
|||
12 October 2013 Saturday |
|||||
Iron Overload |
|||||
09:00-09:30 |
How I treat my hemoglobinopathy patients? |
Dr. Maria Domenica Cappellini |
|||
09:30-10:00 |
Methods to quantify Iron Overload. How reliable is ferritin plasmatic concentration? |
Dr. Antonio Piga |
|||
10:00-10:30 |
Stem Cell Transplantation and Gene Therapy in the B-Hemoglobinopathies |
Dr. Emanuele Angelucci |
|||
10:30-10:45 |
Coffee Break |
||||
AML |
|||||
10.45-11:15 |
Aplastic Anemia: Therapeutic Updates in Immunosuppression and Transplantation |
Dr. Emanuele Angelucci |
|||
11:15-11:45 |
APL: A Curable Leukemia Without Chemotherapy |
Dr. Erdal Kurtoglu |
|||
11:45-12:15 |
Minimal Residual Disease in Acute Myeloid Leukemis: Coming of Age |
Dr. Mehmet Yilmaz |
|||
12:45-13:30 |
Lunch Break |
||||
CML |
|||||
13:30-14:00 |
Key considerations for treatment success in CML |
Dr. Elias Jabbour |
|||
Special Topics |
|||||
14:00-14:30 |
PNH, Atypical HUS |
Dr. Mustafa Nuri Yenerel |
|||
14:30-15:00 |
ITP , New Treatment Strategy |
Dr. Fahri Sahin |
|||
15:00-15:15 |
Coffee Break |
||||
Poster Awards and Presentations |
|||||
15:15-15:45 |
Poster Awards and Presentations |
||||
Special Topics |
|||||
15:45-16:15 |
Hemophilia, Outcome and Complication |
Dr. Alphan Kupesiz |
|||
16:15-16:45 |
Basic Plasma Fractionation |
Dr. Zera Tellier |
|||
16:45-17:15 |
Hemophilia Gene Therapy |
Dr. Bulent Antmen |
|||
17:15-18.15 |
Rational Use of Drugs |
Dr. Kamil Vural |
|||
